--- title: Remote Therapeutic Monitoring to Support Adoption of Bispecific Antibodies Therapy in Community Practices description: Remote Therapeutic Monitoring to Support Adoption of Bispecific Antibodies Therapy in Community Practices image: https://canopycare.us/hubfs/aFAgnrNJEFaPX_jX_JCPlogoforblog.png.avif --- [Skip to content](https://canopycare.us/blog/jcp-rtm-bisepcific-antibodies#main-content) [![Canopy](https://canopycare.us/hubfs/website/brand/canopy-logo.svg)](https://canopycare.us/) [About](https://canopycare.us/about)[Life Sciences](https://canopycare.us/life-sciences)[Careers](https://canopycare.us/careers)[News](https://canopycare.us/blog) [Log In](https://login.canopycare.us/)[Schedule Demo](https://get.canopycare.us/l/1089072/2024-12-23/3dfnp4) [Clinical](https://canopycare.us/blog/tag/clinical) # Remote Therapeutic Monitoring to Support Adoption of Bispecific Antibodies Therapy in Community Practices June 16, 2025 Tags: [Clinical](https://canopycare.us/blog/tag/clinical) ## Featured in: Journal of Clinical Pathways Author(s): [James H. Essell, MD](https://www.hmpgloballearningnetwork.com/taxonomy/term/1097160) | [Benjamin A. Derman, MD](https://www.hmpgloballearningnetwork.com/taxonomy/term/1209295) | [Barry Brooks, MD](https://www.hmpgloballearningnetwork.com/taxonomy/term/1096743) | [Gurjyot K. Doshi, MD](https://www.hmpgloballearningnetwork.com/taxonomy/term/1209298) | [Michael Kolodziej, MD](https://www.hmpgloballearningnetwork.com/taxonomy/term/1097455) | [Lavi Kwiatkowsky](https://www.hmpgloballearningnetwork.com/taxonomy/term/1209301) | [Geoffrey Calkins](https://www.hmpgloballearningnetwork.com/taxonomy/term/1209304) | [Mustafa S. Ascha, PhD, MS](https://www.hmpgloballearningnetwork.com/taxonomy/term/1209307) Source: [*J Clin Pathways*. 2025;11(3):19-26. doi:10.25270/jcp.2025.05.02](https://www.hmpgloballearningnetwork.com/site/jcp/review/remote-therapeutic-monitoring-support-adoption-bispecific-antibody-therapy) Bispecific antibodies (BsAbs) are reshaping oncology treatment, but their complex toxicity profiles present unique barriers to outpatient adoption—particularly in community practices. A new review in the [*Journal of Clinical Pathways*](https://www.hmpgloballearningnetwork.com/site/jcp/review/remote-therapeutic-monitoring-support-adoption-bispecific-antibody-therapy)*,* featuring authors from Canopy, outlines how Remote Therapeutic Monitoring (RTM) using electronic patient-reported outcomes (ePROs) can support the adoption of BsAbs in the outpatient setting by enabling earlier detection of symptoms, standardizing toxicity management, and reducing operational toxicity for clinical teams. The manuscript reviews real-world findings on RTM use with BsAbs, including data from Canopy’s RTM platform, first presented at the 2024 American Society of Hematology (ASH) Meeting: - RTM identifies BsAb-related symptoms up to three weeks earlier than traditional phone-based follow-up.¹ - Nearly all symptoms were reported more frequently through RTM compared to phone, including key toxicities¹ These studies build on Canopy’s broader RTM research, which have demonstrated: - 45% improvement in treatment persistence at three months² - 22% reduction in ER visits/hospitalizations per 100 patient months³ - 88% patient engagement sustained at six months⁴ Read the full review in the [*Journal of Clinical Pathways*](https://www.hmpgloballearningnetwork.com/site/jcp/review/remote-therapeutic-monitoring-support-adoption-bispecific-antibody-therapy)*.* [Read the Review](https://www.hmpgloballearningnetwork.com/site/jcp/review/remote-therapeutic-monitoring-support-adoption-bispecific-antibody-therapy)   ##### References 1. [Derman, B. A., Essell, J. H., Kolodziej, M. A., Kwiatkowsky, L., Calkins, G., Parrinello, C. M., & Ascha, M. S. (2024, December 9). Electronic patient-reported outcome (ePRO) symptom monitoring for relapsed/refractory multiple myeloma in community settings, focusing on bispecific antibody therapy. American Society of Hematology Annual Meeting](https://ash.confex.com/ash/2024/webprogram/Paper206505.html) 2. [Parrinello, C., Calkins, G., Kwiatkowsky, L., Schaefer, E. S., Beck, J. T., Ellis, A. R., Blau, S., Telivala, B. P., & Kolodziej, M. A. (2022). Time on treatment is prolonged in patients utilizing an ePRO based digital symptom monitoring platform in the community setting. Journal of Clinical Oncology, 40(16\_suppl), 1528. DOI: 10.1200/JCO.2022.40.16\_suppl.1528](https://meetings.asco.org/abstracts-presentations/212421) 3. [Kolodziej, M. A., Kwiatkowsky, L., Parrinello, C., Thurow, T., Schaefer, E. S., Beck, J. T., Cherny, N., & Blau, S. (2022). ePRO-based digital symptom monitoring in a community oncology practice to reduce emergency room and inpatient utilization. Journal of Clinical Oncology, 40(16\_suppl), 1508](https://meetings.asco.org/abstracts-presentations/208040) 4. [Cherny, N. I., Parrinello, C. M., Kwiatkowsky, L., Hunnicutt, J., Beck, T., Schaefer, E., Thurow, T., & Kolodziej, M. (2022). Feasibility of Large-Scale Implementation of an Electronic Patient- Reported Outcome Remote Monitoring System for Patients on Active Treatment at a Community Cancer Center. JCO Oncology Practice, 18(12), e1918-e1926. DOI: 10.1200/OP.22.00180](https://ascopubs.org/doi/full/10.1200/OP.22.00180) ### Contact Us 228 Park Ave S Suite 72460 New York, NY 10003-1502 ### Navigation - [About](https://canopycare.us/about) - [Life Sciences](https://canopycare.us/life-sciences) - [Careers](https://canopycare.us/careers) - [News](https://canopycare.us/blog) ### Stay Connected [Sign up for our newsletter](http://get.canopycare.us/l/1089072/2024-12-27/3dfpft) to learn more about our product updates. © 2026 Canopy Oncology. All Rights Reserved. [Privacy Policy](https://canopycare.us/privacy-policy) [Patient Agreement](https://canopycare.us/patient-agreement) [Vulnerability Disclosure](https://canopycare.us/vulnerability-disclosure) ```json { "@context" : "https://schema.org", "@type" : "BlogPosting", "author" : { "@type" : "Person", "name" : "Admin", "url" : "https://canopycare.us/blog/author/admin" }, "dateModified" : "2025-11-20T13:42:32.210Z", "datePublished" : "2025-06-16T04:00:00.000Z", "headline" : "Remote Therapeutic Monitoring to Support Adoption of Bispecific Antibodies Therapy in Community Practices", "image" : [ "https://canopycare.us/hubfs/aFAgnrNJEFaPX_jX_JCPlogoforblog.png.avif" ], "mainEntityOfPage" : { "@id" : "https://canopycare.us/blog/jcp-rtm-bisepcific-antibodies", "@type" : "WebPage" }, "publisher" : { "@type" : "Organization", "logo" : { "@type" : "ImageObject", "url" : "https://canopycare.us/hubfs/Canopy_WordMark_Primary_LifeGreen.png" }, "name" : "Canopy" } } ```